Latest news

7e Challenge Qualité de vie du patient : cinq finalistes reçoivent 5000 francs chacun et avancent en finale

Debiopharm leads investment round for evidence-based digital cancer therapeutic app Mika to empower cancer patients

VivoSense Announces Closing of $25M Series A Financing Round Co-led by Xontogeny and Debiopharm

Challenge pour la Qualité de vie du patient 2022 : l’appel à projets est ouvert !

Debiopharm and Aspen Partner to Launch Prostate Cancer Drug Trelstar® in South Africa

Debiopharm invests in VeriSIM Life’s $15m series A round to advance AI-enabled drug research

Debiopharm further explores the potential of its potent, highly selective WEE1 inhibitor Debio 0123 in phase 1 cancer study

Grand gagnant du 6eme Challenge 2021 pour la qualité de vie du patient, le projet WheelyWasher permet de nettoyer automatiquement…

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…